The owner of Sensodyne, Panadol and Centrum has posted a 3.3% downturn in revenue to £2.79bn in the third quarter of its financial year. Haleon was spun out from GSK in July last year.
Consumer healthcare giant Haleon sees dip in revenue
Share
Join our network of executives who receive the MBS News daily, as well as the insights, analysis and our weekly column in The Weekend Edition.
You’ll be able to unsubscribe at any time.